Inflammation is well documented in CRPS, with elevated levels of biomarkers such as substance P (SP), calcitonin gene-related peptide (CGRP), interleukin-6 (IL-6), and tumor necrosis factor (TNF-α), though their reliability remains uncertain [11,12]. This evidence concerns the gene IL6 and complex regional pain syndrome.